Boster Biological Technology advances biotechnology research with its cutting-edge multiplex ELISA service, delivering ...

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters ...

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

The use of immunosuppressive drugs has increased significantly since ... Patients treated with cytokine/integrin inhibitors, TKI therapies, or JAK inhibitors Patients undergoing TACE.

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Cytokinetics' hopes of resurrecting cardiac myosin activator omecamtiv mecarbil have suffered another setback, after the drug failed to show a benefit in a phase 3 heart failure study.

[8] The analysis concluded that these drugs, taken long term, could be most useful in patients who have repeated, prolonged or severe exacerbations of COPD. Hence, in some European and extra ...

Our mission is to provide a state-of-the-art facility, expertise, and education in advanced quantitative light microscopy to support Drexel University’s research community The Cell Imaging Center (CIC ...